June 8, 2020 / 12:48 PM / a month ago

BRIEF-Vectura Group Signs Global Licence And Development Agreement With Aerami Therapeutics

June 8 (Reuters) - Vectura Group Plc:

* VECTURA GROUP PLC - SIGNING OF A GLOBAL LICENCE AND DEVELOPMENT AGREEMENT WITH AERAMI THERAPEUTICS

* VECTURA GROUP PLC - AGREEMENT TO SUPPORT DEVELOPMENT OF INHALED IMATINIB (VR325) FOR TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

* VECTURA GROUP PLC - AERAMI WILL BE RESPONSIBLE FOR OVERALL DEVELOPMENT AND COMMERCIALISATION OF INHALED IMATINIB

* VECTURA GROUP - VECTURA PROVIDING DEVELOPMENT SERVICES EXPERTISE, LICENSE TO ITS FOX MESH NEBULISER TECHNOLOGY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below